Valuation: Coloplast

Market Cap 93.51B 14.07B 12.5B 11.68B 10.66B 19.99B 1,355B 20.29B 141B 54.73B 690B 52.81B 51.66B 2,222B P/E 2026 *
26.8x
P/E 2027 * 16x
Enterprise Value 114B 17.14B 15.22B 14.23B 12.99B 24.36B 1,650B 24.71B 172B 66.67B 841B 64.33B 62.94B 2,707B EV / Sales 2026 *
3.95x
EV / Sales 2027 * 3.67x
Free-Float
63.42%
Yield 2026 *
4.91%
Yield 2027 * 5.21%
Manager TitleAgeSince
Chief Executive Officer 55 30/04/2026
Director of Finance/CFO 54 31/12/2005
Chief Operating Officer 59 04/09/2008
Director TitleAgeSince
Director/Board Member 79 12/12/2006
Director/Board Member 56 17/09/2009
Chairman 58 04/05/2025
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 14.3B
-2.17%-6.57%-27.81%-0.17% 171B
+0.17%-3.20%-9.24%+10.31% 110B
-0.88%-0.16%-26.16%-0.11% 106B
-0.69%-3.57%-47.61%-12.45% 75.99B
+3.17%-0.80%-0.88%+72.13% 57.3B
-0.52%-2.44%-4.86%-31.12% 48.76B
+3.44%+7.90%+19.12%+59.15% 50.19B
-0.85%-0.82%-18.96%+18.41% 41.14B
-0.07%-1.71%+28.15%-7.58% 32.56B
Average +0.16%-1.46%-9.81%+12.06% 77B
Weighted average by Cap. -0.29%-2.07%-16.38%+9.01%

Financials

2026 *2027 *
Net sales 28.86B 4.34B 3.86B 3.61B 3.29B 6.17B 418B 6.26B 43.54B 16.89B 213B 16.3B 15.94B 686B 30.81B 4.63B 4.12B 3.85B 3.51B 6.59B 446B 6.68B 46.48B 18.03B 227B 17.4B 17.02B 732B
Net income 3.55B 534M 474M 443M 405M 759M 51.41B 770M 5.35B 2.08B 26.2B 2B 1.96B 84.33B 5.85B 879M 781M 730M 666M 1.25B 84.69B 1.27B 8.82B 3.42B 43.16B 3.3B 3.23B 139B
Net Debt 20.4B 3.07B 2.73B 2.55B 2.33B 4.36B 296B 4.43B 30.79B 11.94B 151B 11.52B 11.27B 485B 19.59B 2.95B 2.62B 2.45B 2.23B 4.19B 284B 4.25B 29.55B 11.46B 145B 11.06B 10.82B 465B
Logo Coloplast
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - ostomy care products (35.5%): bags and equipment used following intestinal operations; - hygiene products (32.2%): urine bags, plugs, urinary testing systems and sets, etc.; - wound care and skincare products (14.1%): wound dressings, bandages, creams and gels; - interventional urology products (10%); - voice and respiratory care products (8.2%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.5%), the United States (23.5%), the United Kingdom (14%), France (10.1%), Germany (9.7%) and other (41.2%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA